SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

NCT06364930 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

412

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Dapagliflozin 10mg Tab
DRUG: Placebo 10mg Tab

Sponsor

Chinese University of Hong Kong